Dopamine D1-D2 receptor heteromer (D1-D2 heteromer)

The Dopamine D1-D2 receptor heteromer is a distinct pharmacological entity formed by the physical association of the Dopamine D1 and D2 receptors, primarily localized in the striatum (Rashid et al., 2007, PNAS). Unlike the individual receptors, which signal through Gs or Gi proteins to modulate adenylyl cyclase, this heteromer selectively couples to the Gq/11 protein, triggering the phospholipase C (PLC) pathway and subsequent intracellular calcium mobilization (Hasbi et al., 2009, FASEB J). This unique signaling profile activates calcium-dependent molecules like CaMKII, which are critical for regulating neuronal excitability and motor behavior. Dysregulation of the D1-D2 heteromer has been implicated in the pathophysiology of several neuropsychiatric conditions, including schizophrenia, where increased heteromer formation is observed, and major depression, where its disruption may play a role (Perreault et al., 2010, J. Neurosci; Pei et al., 2010, Nature Communications). Pharmacological agents like the agonist SKF-83959 specifically target this complex, offering a potential therapeutic avenue for modulating dopaminergic pathways with higher precision than traditional monomer-targeted drugs (George et al., 2014, Frontiers in Endocrinology). Consequently, the D1-D2 heteromer represents a significant target for developing next-generation antipsychotics and antidepressants with potentially improved safety profiles.

Other names

D1-D2 receptor complexD1R-D2R heteromerDopamine D1-D2 receptor heterooligomerD1-D2 heteromer

Selective activation of the Gq/11-phospholipase C-calcium signaling pathway, which is distinct from the Gs or Gi pathways utilized by the individual monomeric receptors.